The Understanding of Terminal Cancer and Its Relationship with Attitudes toward End-of-Life Care Issues
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, June Koo | - |
dc.contributor.author | Yun, Young Ho | - |
dc.contributor.author | An, Ah Reum | - |
dc.contributor.author | Heo, Dae Seog | - |
dc.contributor.author | Park, Byeong-Woo | - |
dc.contributor.author | Cho, Chi-Heum | - |
dc.contributor.author | Kim, Sung | - |
dc.contributor.author | Lee, Dae Ho | - |
dc.contributor.author | Lee, Soon Nam | - |
dc.contributor.author | Lee, Eun Sook | - |
dc.contributor.author | Kang, Jung Hun | - |
dc.contributor.author | Kim, Si-Young | - |
dc.contributor.author | Lee, Jung Lim | - |
dc.contributor.author | Lee, Chang Geol | - |
dc.contributor.author | Lim, Yeun Keun | - |
dc.contributor.author | Kim, Samyong | - |
dc.contributor.author | Choi, Jong Soo | - |
dc.contributor.author | Jeong, Hyun Sik | - |
dc.contributor.author | Chun, Mison | - |
dc.date.accessioned | 2021-09-05T06:33:29Z | - |
dc.date.available | 2021-09-05T06:33:29Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-08 | - |
dc.identifier.issn | 0272-989X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97863 | - |
dc.description.abstract | Background. Although terminal cancer is a widely used term, its meaning varies, which may lead to different attitudes toward end-of-life issues. The study was conducted to investigate differences in the understanding of terminal cancer and determine the relationship between this understanding and attitudes toward end-of-life issues. Methods. A questionnaire survey was performed between 2008 and 2009. A total of 1242 cancer patients, 1289 family caregivers, 303 oncologists from 17 hospitals, and 1006 participants from the general population responded. Results. A 6-month life expectancy was the most common understanding of terminal cancer (45.6%), followed by treatment refractoriness (21.1%), metastatic/recurrent disease (19.4%), survival of a few days/weeks (11.4%), and locally advanced disease (2.5%). The combined proportion of treatment refractoriness and 6-month life expectancy differed significantly between oncologists and the other groups combined (76.0% v. 65.9%, P = 0.0003). Multivariate analyses showed that patients and caregivers who understood terminal cancer as survival of a few days/weeks showed more negative attitudes toward disclosure of terminal status compared with participants who chose treatment refractoriness (adjusted odds ratio [aOR] 0.42, 95% confidence interval [CI] 0.22-0.79 for patients; aOR 0.34, 95% CI 0.18-0.63 for caregivers). Caregivers who understood terminal cancer as locally advanced or metastatic/recurrent disease showed a significantly lower percentage of agreement with withdrawal of futile life-sustaining treatment compared with those who chose treatment refractoriness (aOR 0.19, 95% CI 0.07-0.54 for locally advanced; aOR 0.39, 95% CI 0.21-0.72 for metastatic/recurrent). Conclusions. The understanding of terminal cancer varied among the 4 participant groups. It was associated with different preferences regarding end-of-life issues. Standardization of these terms is needed to better understand end-of-life care. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS INC | - |
dc.subject | PALLIATIVE CARE | - |
dc.subject | FAMILY CAREGIVERS | - |
dc.subject | SURVIVAL PREDICTION | - |
dc.subject | PHYSICIANS | - |
dc.subject | PREFERENCES | - |
dc.subject | PATIENT | - |
dc.subject | CONCORDANCE | - |
dc.subject | DISCLOSURE | - |
dc.subject | ILLNESS | - |
dc.subject | DISEASE | - |
dc.title | The Understanding of Terminal Cancer and Its Relationship with Attitudes toward End-of-Life Care Issues | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Eun Sook | - |
dc.identifier.doi | 10.1177/0272989X13501883 | - |
dc.identifier.scopusid | 2-s2.0-84907054874 | - |
dc.identifier.wosid | 000342641400004 | - |
dc.identifier.bibliographicCitation | MEDICAL DECISION MAKING, v.34, no.6, pp.720 - 730 | - |
dc.relation.isPartOf | MEDICAL DECISION MAKING | - |
dc.citation.title | MEDICAL DECISION MAKING | - |
dc.citation.volume | 34 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 720 | - |
dc.citation.endPage | 730 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | Medical Informatics | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.relation.journalWebOfScienceCategory | Medical Informatics | - |
dc.subject.keywordPlus | PALLIATIVE CARE | - |
dc.subject.keywordPlus | FAMILY CAREGIVERS | - |
dc.subject.keywordPlus | SURVIVAL PREDICTION | - |
dc.subject.keywordPlus | PHYSICIANS | - |
dc.subject.keywordPlus | PREFERENCES | - |
dc.subject.keywordPlus | PATIENT | - |
dc.subject.keywordPlus | CONCORDANCE | - |
dc.subject.keywordPlus | DISCLOSURE | - |
dc.subject.keywordPlus | ILLNESS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordAuthor | terminal cancer | - |
dc.subject.keywordAuthor | end of life | - |
dc.subject.keywordAuthor | terminology | - |
dc.subject.keywordAuthor | life-sustaining treatment | - |
dc.subject.keywordAuthor | palliative care | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.